{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"myasthenia-congenital-refractory-to-acetylcholinesterase-inhibitors","columns":[{"gene":"","key":"population-99290ccfffe1ccc7b181","label":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","mondoId":"MONDO:0009687","onsetQualifier":null,"originColumnKey":"MONDO:0009687/OMIM:254190","originalViews":[{"key":"MONDO:0009687/OMIM:254190","label":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","scopeLabel":"OMIM:254190","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0ac7b8e3d51fc0352a1a25518c2e2619468f06bf840ede02d367ababeccfe234","11396cf559b45a43b0f504dc84cad67c1e55806e7c96b0aeca3d114db931aa70","9537490837fd630c9b803042df52f547983f7db47ed8ec25986e469aabe67e25","a53fd059b3fe11442ef62fa51eeaa0d9929fc7798589394303b17e5ac22ae08f","c66b76664aef7727dd960e21e2ab052d07915611633a6f75f26f3a60128e39fb"],"recordQualifiers":{},"scopeLabel":"OMIM:254190","sourceIds":["OMIM:254190"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-99290ccfffe1ccc7b181"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001939","HP:0007970","HP:0000544","HP:0003473","HP:0003701"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":5,"sourceGroups":{"omim":5}},"features":[{"hpoId":"HP:0001939","label":"Abnormality of metabolism/homeostasis","primary":true},{"hpoId":"HP:0007970","label":"Congenital ptosis","primary":true},{"hpoId":"HP:0000544","label":"External ophthalmoplegia","primary":true},{"hpoId":"HP:0003473","label":"Fatigable weakness","primary":true},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":true}],"ledeHtml":"","mondoId":"MONDO:0009687","node":{"canonicalSlug":"myasthenia-congenital-refractory-to-acetylcholinesterase-inhibitors","comparisons":[{"documentSha256":"03ca9a31d3921a2105c968f187a8e24ff8c91c54743f2e41056ef482e6bdeb19","key":"expanded-neuromuscular-junction-disease","kind":"expanded","label":"neuromuscular junction disease","memberIds":["MONDO:0000182","MONDO:0009687","MONDO:0009689","MONDO:0009690","MONDO:0011088","MONDO:0011281","MONDO:0011600","MONDO:0012156","MONDO:0012157","MONDO:0012518","MONDO:0013620","MONDO:0013883","MONDO:0014052","MONDO:0014468","MONDO:0014542","MONDO:0014543","MONDO:0014578","MONDO:0014581","MONDO:0014582","MONDO:0014583","MONDO:0014584","MONDO:0014585","MONDO:0014586","MONDO:0014587","MONDO:0014588","MONDO:0014590","MONDO:0014745","MONDO:0014939","MONDO:0014983","MONDO:0018940","MONDO:0020124","MONDO:0020344","MONDO:0030341","MONDO:0032596","MONDO:0032597","MONDO:0032675","MONDO:0044299","MONDO:0700466","MONDO:1040021"],"mondoId":"MONDO:0020124","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-03ca9a31d3921a2105c9.03ca9a31d3921a2105c968f187a8e24ff8c91c54743f2e41056ef482e6bdeb19.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-99290ccfffe1ccc7b181"],"publication":"published","relationships":[{"kind":"parent","label":"congenital nervous system disorder","mondoId":"MONDO:0002320","slug":null},{"kind":"parent","label":"congenital myasthenic syndrome","mondoId":"MONDO:0018940","slug":"congenital-myasthenic"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24687"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0ac7b8e3d51fc0352a1a25518c2e2619468f06bf840ede02d367ababeccfe234","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:254190","disease_name":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003473","is_excluded":false,"label":"Fatigable weakness","onset_id":null,"reference":"OMIM:254190","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"11396cf559b45a43b0f504dc84cad67c1e55806e7c96b0aeca3d114db931aa70","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:254190","disease_name":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001939","is_excluded":false,"label":"Abnormality of metabolism/homeostasis","onset_id":null,"reference":"OMIM:254190","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9537490837fd630c9b803042df52f547983f7db47ed8ec25986e469aabe67e25","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:254190","disease_name":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000544","is_excluded":false,"label":"External ophthalmoplegia","onset_id":null,"reference":"OMIM:254190","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a53fd059b3fe11442ef62fa51eeaa0d9929fc7798589394303b17e5ac22ae08f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:254190","disease_name":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"OMIM:254190","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c66b76664aef7727dd960e21e2ab052d07915611633a6f75f26f3a60128e39fb","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:254190","disease_name":"Myasthenia, congenital, refractory to acetylcholinesterase inhibitors","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007970","is_excluded":false,"label":"Congenital ptosis","onset_id":null,"reference":"OMIM:254190","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"myasthenia-congenital-refractory-to-acetylcholinesterase-inhibitors","sourceDocuments":[],"sourceNote":"","synonyms":["myasthenia, congenital, refractory to acetylcholinesterase inhibitors"],"takeawayHtml":"","title":"myasthenia, congenital, refractory to acetylcholinesterase inhibitors"},"schemaVersion":1}
